StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.1
  1. Startseite
  2. /Verbindung

Hydrazinium(2+)-sulfat

Hydrazine Sulfate

HCID 24842
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
10034-93-2
Standard-SMILES
NN.O=S(=O)(O)O
InChIKey
ZGCHATBSUIJLRL-UHFFFAOYSA-N
Summenformel
H4N2.H2O4S
Durchschnittliche Molmasse
130,13 g/mol
Monoisotopische Masse
130,00482767

Überblick

Hydrazine sulfate can cause cancer according to an independent committee of scientific and health experts.

Namen und Bezeichner

Bevorzugter Name
Hydrazine Sulfate
IUPAC
hydrazine;sulfuric acid
Lokaler Name
Hydrazinium(2+)-sulfat
Englischer Name
Hydrazine sulfate
Summenformel
H6N2O4S
Molmasse
130.12

Namen und Synonyme

Hydrazine sulfate10034-93-2Hydrazine monosulfateHydrazinium sulfateHydrazine sulphateHydrazine, sulfate (1:1)Hydrazonium sulfateHydrazine sulfate (1:1)SegidrinSehydrinDiamine sulfateSiran hydrazinu
Weitere Namen anzeigen
siranhydrazinuidrazinasolfatoHydrazine sulfaDiamine SucfateHydrazine Sulfat
Idrazina solfatoDiamidogen sulfateHydrazinium(2+) sulfateHYDRAZINE HYDROGEN SULFATENSC-150014Hydrazine dihydrogen sulfate saltHydrazinium sulphateDTXSID8020703

Datenbank-Bezeichner

CAS
10034-93-2、1184-66-3
PubChem CID
24842
DTXSID
DTXSID8020703
ChEMBL
CHEMBL1981828
ChEBI
CHEBI:232153
UNII
1N369SAT01
EC Number
233-110-4

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
135 Ų
H-Brücken-Donoren
4
H-Brücken-Akzeptoren
6
Frei drehbare Bindungen
0
Schwere Atome
7
Formalladung
0
Komplexität
81,3

Experimentelle und physikochemische Eigenschaften

Chemical Classes · 2 Einträge

Nitrogen Compounds -> Hydrazines

Carcinogens

pH1.3 (0.2 Molar aq soln)
Density · 3 Einträge

1.37 (NTP, 1992) - Denser than water; will sink

1.378

1.378 @25 °C

Color/Form · 2 Einträge

Orthorhombic crystals; glass like plates or prisms

White crystalline powder

Solubility · 6 Einträge

greater than or equal to 0.1 mg/mL at 70 °F (NTP, 1992)

0.04 g/100 g ethanol at 25 °C

3.41 g/100 g water

14.39 g/100 g water at 80 °C

Water approximately .03 (mg/mL)

Water (hot) freely soluble (mg/mL)

Boiling PointDECOMPOSES (NTP, 1992)
DecompositionWhen heated to decomposition it emits very toxic fumes of /sulfur oxides and nitrogen oxides/.
Melting Point · 2 Einträge

489 °F (NTP, 1992)

254 °C

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 6 Einträge

This chemical does not meet GHS hazard criteria for 0.6% (1 of 162) of reports.

Danger

H301+H311+H331 (89.5%): Toxic if swallowed, in contact with skin or if inhaled [Danger Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]

P203, P260, P261, P262, P264, P264+P265, P270, P271, P272, P273, P280, P301+P316, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P318, P321, P330, P333+P317, P361+P364, P362+P364, P363, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 162 reports by companies from 13 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

Gefahrenhinweise

Regulatory Information · 4 Einträge

Chemical: Hydrazine, sulfate (1:1)

Hazard Traits - Carcinogenicity

Hydrazinium sulphate: Does not have an individual approval but may be used under an appropriate group standard

The New Jersey Worker and Community Right to Know Act requires public and private employers to provide information about hazardous substances at their workplaces. (N.J.S.A. 34:5A-1 et. seq.)

Other Safety InformationIMAP assessments - Hydrazine salts: Human health tier II assessment
DOT LabelCorrosive Poison
Fire HazardsExcerpt from ERG Guide 154 [Substances - Toxic and/or Corrosive (Non-Combustible)]:
Health HazardsACUTE/CHRONIC HAZARDS: Toxic. May cause irritation on contact. Hazardous decomposition products. OSHA category I carcinogen. Mutagen. (NTP, 1992)

Chemie und Industrie

Pharmakologische Informationen

Mechanism of Action · 1 Eintrag

The chemical carcinogen hydrazine is potent stimulator of guanylate cyclase. 1,1-Dimethylhydrazine and hydrazine sulfate, two chemical carcinogens, structurally related to hydrazine decrease guanylate cyclase activity in rat tissues. Hydrazine increased DNA synthesis, but 1,1-dimethylhydrazine & hydrazine sulfate decreased DNA synthesis. The relationship, if any, linking the guanylate cyclase cyclic GMP system to DNA synthesis & carcinogenesis remains to be explored.

Metabolism/Metabolites · 2 Einträge

When hydrazine sulfate (1 mmole/kg) was injected ip in the rat, approx 15% was converted to nitrogen within the first 30 min, followed by a much slower conversion during 24 hr. The highest conversion was observed with iv doses, and lowest with sc doses.

The enzyme systems in rat liver and lung responsible for the oxidative metabolism of hydrazine derivatives were studied to determine whether these enzymes, cytochrome p450 and monoamine oxidase, were responsible for metabolically activating hydrazines to carcinogenic/toxic metabolites. Cytochrome p450 preferentially oxidized the nitrogen to nitrogen bond of 1,2-disubstituted hydrazines and hydrazides, while monoamine oxidase oxidized the nitrogen to nitrogen bond of all the classes of hydrazine derivatives that were tested. Oxidation of the nitrogen to nitrogen bond led to the formation of stable azo intermediates in the case of 1,2-disubstituted hydrazines and to unstable monoazo (diazene) metabolites in the case of monosubstituted hydrazines and hydrazides. /Substituted hydrazines/

MeSH Pharmacological Classification · 2 Einträge

Substances that inhibit or prevent the proliferation of NEOPLASMS.

Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included.

Absorption, Distribution and Excretion · 1 Eintrag

/Following/ a single ip administration to mice, 1 mmol/kg hydrazine sulfate was distributed rapidly to most tissues with highest levels appearing in kidney. Loss from all tissues was extensive by 24 hr. Within 1st 1 to 2 hr after administration of (15)N-hydrazine sulfate, approx 20% of dose was expired as (15)N and by 48 hr another 10-15% was eliminated.

Zugehörige Reaktionen

26
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 15168
HRID 15168als Eduktuspto-grants-2010_06
Reaktionsgleichung von HRID 15175
HRID 15175als Eduktuspto-grants-2010_06
Reaktionsgleichung von HRID 258743
HRID 258743als Eduktuspto-grants-1977_07
Reaktionsgleichung von HRID 258744
HRID 258744als Eduktuspto-grants-1977_07
Reaktionsgleichung von HRID 372942
HRID 372942als Eduktuspto-grants-1992_11
Reaktionsgleichung von HRID 420625
HRID 420625als Eduktuspto-grants-2012_01
Reaktionsgleichung von HRID 568306
HRID 568306als Eduktuspto-grants-1988_03
Reaktionsgleichung von HRID 629201
HRID 629201als Eduktuspto-grants-2016_04
ZurückSeite 1 von 4

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Physical Description · 2 Einträge

Hydrazine sulfate appears as a white crystalline solid. Obtained by neutralizing the base hydrazine with sulfuric acid.

White solid; [Hawley]

Stability/Shelf LifeStable in storage
Dissociation ConstantsExists as zwitterion, macroscopic pKa = 6.7 /Estimated/
Other Experimental Properties · 2 Einträge

Strong reducing agent

Decomposes at bp

Physikochemische Eigenschaften

Schmelzpunkt
254 °C · 254 °C(lit.)
Dichte
1 · 1,37 g/cm3
storage temp.
Keep in dark place,Sealed in dry,Room Temperature
Löslichkeit
30 g/l · 30g/l
Aggregatzustand
Crystalline Powder
Farbe
White
Wichte
1.37 · 1.37
Geruch (Odor)
Odorless
PH
1.5 · 1.5 (50g/l, H2O, 20℃)
Wasserlöslichkeit
30 g/L · 30 g/L (20 ºC)
Merck
14 · 14,4772
BRN
8778859 · 8778859
Stabilität
Stable. Incompatible with nitrites, strong oxidizing agents.
InChI
1S/H4N2.H2O4S/c1-2;1-5(2,3)4/h1-2H2;(H2,1,2,3,4)
InChIKey
ZGCHATBSUIJLRL-UHFFFAOYSA-N
SMILES
NN.OS(O)(=O)=O
CAS Datenbank
10034 · 10034-93-2(CAS DataBase Reference)
NIST chemische Informationen
Hydrazine dihydrogen sulfate (salt)(10034-93-2)
EPA chemische Informationen
Hydrazine sulfate (1:1) (10034-93-2)
Hazards Summary · 1 Eintrag

Emergency treatment: Hydrazines; Hydrazines can cause severe eye damage. They can cause seizures, liver injury, hemolysis, and delayed pulmonary edema. [HSDB] A strong reducing agent; May cause irritation; [CAMEO] An irritant; May cause skin sensitization; May be fatal by inhalation; [MSDSonline] See Hydrazine.

Reactive GroupAzo, Diazo, Azido, Hydrazine, and Azide Compounds
Special Reports · 2 Einträge

National Toxicology Program. Eleventh Report on Carcinogens (2005). The Report on Carcinogens is an informational scientific and public health document that identifies and discusses substances (including agents, mixtures, or exposure circumstances) that may pose a carcinogenic hazard to human health. Hydrazine Sulfate (10034-93-2) is listed as reasonably anticipated to be a human carcinogen.[Available from, as of July 31, 2009: http://ntp.niehs.nih.gov/ntp/roc/eleventh/profiles/s096hydr.pdf]

Toth B; Teratogenic hydrazines: a review; In Vivo Jan-Feb 7 (1): 101-10 (1993). The review summarizes the results of 30 hydrazines, which were studied in humans and in six animal species for teratogenic activities.

Reactivity AlertsStrong Reducing Agent
Reactivity ProfileHYDRAZINE SULFATE is a strong reducing agent. Aqueous solutions are weakly acidic.
Air and Water ReactionsWater soluble.
Hazard Classes and Categories · 5 Einträge

Acute Tox. 3 (99.4%)

Acute toxicity - category 3

Acute toxicity (Oral) - Category 4

Acute toxicity (Oral) - Category 4

Carcinogens

Sicherheit und Schutzausrüstung

Fire Fighting · 1 Eintrag

This compound is not very flammable but any fire involving this compound may produce dangerous vapors. You should evacuate the area. All firefighters should wear full-body protective clothing and use self-contained breathing apparatuses. You should extinguish any fires involving this chemical with a dry chemical, carbon dioxide, foam, or halon extinguisher. (NTP, 1992)

First Aid · 1 Eintrag

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1 Eintrag

SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a strong soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Disposal Methods · 2 Einträge

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations.

Incineration: The best disposal methods are incineration and burial. Incinerate in a unit with effluent gas scrubbing.

Preventive Measures · 3 Einträge

Inhalation of salt dusts should be avoided. /Hydrazine & derivatives/

Engineering controls, such as process enclosure or local exhaust ventilation, shall be used when needed to keep concentrations of airborne hydrazines within acceptable levels. Ventilation systems shall be designed to prevent accumulation or recirculation of airborne hydrazines in the workplace environment and to remove hydrazines from the breathing zone of workers.

SRP: The scientific literature for the use of contact lenses in industry is conflicting. The benefit or detrimental effects of wearing contact lenses depend not only upon the substance, but also on factors including the form of the substance, characteristics and duration of the exposure, the uses of other eye protection equipment, and the hygiene of the lenses. However, there may be individual substances whose irritating or corrosive properties are such that the wearing of contact lenses would be harmful to the eye. In those specific cases, contact lenses should not be worn. In any event, the usual eye protection equipment should be worn even when contact lenses are in place.

Isolation and EvacuationExcerpt from ERG Guide 154 [Substances - Toxic and/or Corrosive (Non-Combustible)]:
Protective Action Criteria (PAC) · 3 Einträge

0.13 [mg/m3]

1.5 [mg/m3]

8.8 [mg/m3]

Personal Protective Equipment (PPE) · 2 Einträge

MINIMUM PROTECTIVE CLOTHING: If Tyvek-type disposable protective clothing is not worn during handling of this chemical, wear disposable Tyvek-type sleeves taped to your gloves.

... Vinyl coated hand protection, natural or reclaimed rubber protection, rubber aprons, and plastic eye and face protection ... used when working with small quantities. Where possibility of gross splashing exists, full protective clothing made of rubber, neoprene or vinyl-coated materials should be worn. For respiratory protection in situations where recommended tolerance limits are ... exceeded, respiratory protective equipment ... must be used. /Hydrazine and derivatives/

Toxikologische Informationen

InteractionsHydrazine sulfate potentiated the antitumor action of cyclophosphamide, mitomycin c, methotrexate, and bleomycin against Walker 256 intramuscular carcinosarcoma in rats.
Adverse EffectsNeurotoxin - Other CNS neurotoxin
Medical Surveillance · 1 Eintrag

Placement medical examinations shall include at least: comprehensive medical and work histories; comprehensive physical examination; specific clinical tests including complete and differential blood count; liver function tests including serum glutamic-pyruvic transaminase (SGPT), urinalysis including specific gravity, glucose, protein, and microscopic examination, and a 14 x 17 inch posteroanterior chest roentenogram; a judgement of the worker's ability to use positive pressure respirators; and urobilinogen and serum bilirubin tests shall be considered by the responsible physician. Periodic examinations shall be made available at least annually to those working with hydrazines. /Hydrazines/

TSCA Test Submissions · 3 Einträge

Clastogenic activity was evaluated in 3 cultures of RL1 rat liver cells per dose, exposed for 22 hours to hydrazine sulfate at concentrations of 0, 25.0, 50.0, or 100.0 ug/ml of culture medium. Concentrations were chosen to be approximately 1/4, 1/2, and 1x the GI50 (concentration at which 50% growth inhibition is achieved). Both positive (7,12-dimethylbenzanthracene) and solvent (water) controls were used. No metabolic activation system was used. Cell division was arrested, and at least 290 metaphases from each test concentration were examined. Neither chromatid aberrations nor chromosome aberrations were increased significantly. The proportions of cells showing chromatid aberrations were 1.3%, 0.3%, 1.4%, and 1.1% at 0.0, 25.0, 50.0, and 100.0 ug/ml, respectively. The proportions of cells showing chromosome aberrations were 1.0%, 0.7%, 0.3%, and 0.3% at 0.0, 25.0, 50.0, and 100.0 ug/ml, respectively. Although the positive control compound induced chromatid aberrations in 8.4% of cells, only 1.0% showed chromosomal aberrations.

Hydrazine sulfate was evaluated for genotoxicity in vitro in human Passage 23 WI-38 fibroblasts exposed for 90 minutes to concentrations of 1X10E-7, 1X10E-6, 1X10E-5, 1X10E-4, and 1X10E-3 M test compound in the presence of 1 microCi/ml of 3H-thymidine (6.7 Ci/ml), followed by exposure to only 3H-thymidine for 3 hours. The rate of unscheduled DNA synthesis (UDS) in hepatocytes was determined by measuring the extent of incorporation of labeled thymidine into DNA, using a scintillation counter; results were expressed per unit of DNA. The rate of UDS in treated cell cultures ranged from 0.59-1.12 times that of the negative control, indicating that the test compound was negative for UDS in human fibroblasts under the conditions of this assay. Positive control treatment with 4-nitroquinoline oxide (1X10E-5 M) produced the expected high increase in UDS (23.63 times that of solvent control).

Hydrazine sulfate was evaluated for genotoxicity in vitro in human Passage 23 WI-38 fibroblasts exposed for 30 minutes to 5 semilog dilutions (concentrations not reported) of the test compound, followed by exposure to 3H-thymidine for 3 hours. Trials were performed on cell cultures both in the presence and absence of Arochlor-induced rat liver S-9 metabolic activation. The rate of unscheduled DNA synthesis (UDS) in hepatocytes was determined by measuring the extent of incorporation of labeled thymidine into DNA, using autoradiography. The maximum rate of UDS in treated cell cultures (1.8 net grains/nucleus) was not significantly greater than that of the negative controls (<1 net grain/ nucleus), indicating that the test compound was negative for UDS in human fibroblasts under the conditions of this assay. This ... response was obtained in the presence of metabolic activation.

Human Toxicity Excerpts · 2 Einträge

/CASE REPORTS/ A 55-year-old man with squamous-cell carcinoma of the left maxillary sinus presented with a 2-week history of rash, pruritus, progressive malaise, and jaundice. The patient had previously declined to undergo surgery, radiation, and chemotherapy. To treat his cancer, the patient had instead decided to use hydrazine sulfate he obtained through an alternative medicine Internet site. ...Two weeks before his presentation, he had discontinued /4 months/ use of hydrazine sulfate, 180 mg/d, after a bothersome rash developed. On physical examination, ... he was alert and conversant. There was no sinus tenderness or obvious facial asymmetry, and no masses were seen in the nasal passages. Inspection of the skin revealed a macular rash involving the chest and extremities, as well as prominent palmar erythema. Marked scleral icterus and jaundice were also evident. No hepatomegaly or other stigmata of liver disease were noted, and the remainder of the examination was normal. Laboratory studies revealed marked azotemia with a serum urea nitrogen level of 15.7 mmol/L (44 mg/dL) and a serum creatinine level of 450.8 umol/L (5.1 mg/dL). Results on liver function tests were as follows: serum aspartate aminotransferase level, 12.8 ukat/L (770 U/L); serum alanine aminotransferase level, 13 533.6 nkat/L (812 U/L); serum lactate dehydrogenase level, 9.8 ukat/L (586 U/L); serum bilirubin level, 738.7 umol/L (43.2 mg/dL); serum albumin level, 28 g/L; and prothrombin time, 19.5 seconds. A complete blood count revealed a leukocyte count of 19.2 x 109 cells/L, a hemoglobin level of 167 g/L, a hematocrit of 0.497, and a platelet count of 111 x 109 cells/L. Findings on electrocardiography, chest radiography, and abdominal ultrasonography were unremarkable. The patient was admitted to the hospital for hepatorenal failure associated with self-medication with hydrazine sulfate. Because hydrazine sulfate is a known antagonist of vitamin B6, this vitamin was administered intravenously. On the third day of hospitalization, the patient developed hepatic encephalopathy that did not respond to lactulose. Progressive renal failure necessitated the initiation of hemodialysis, and coagulopathy persisted despite administration of vitamin K and several blood plasma transfusions. On the seventh hospital day, hematemesis occurred and prompted esophagoduodenoscopy, which revealed erosive esophagitis and diffuse hemorrhagic gastritis. No esophageal or gastric varices were detected. The patient never recovered from this episode despite aggressive treatment.

/CASE REPORTS/ After 180 mg/day for 2 wks followed by 360 mg/day of hydrazine sulfate ingestion, our patient suffered severe encephalopathy. He received mechanical ventilation with attendant supportive measures and high-dose pyridoxine. The patient's encephalopathy resolved 24 hrs after receiving pyridoxine.

Non-Human Toxicity Excerpts · 5 Einträge

/LABORATORY ANIMALS: Acute Exposure/ Neutral salt, hydrazine sulfate has been found not to be injurious to rabbit eye when applied at 0.02 molar concentration for 10 min after mechanical removal of corneal epithelium to facilitate penetration.

/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ ... 25 newborn BALB/c/Cb/Se mice /treated/ with increasing doses of /hydrazine sulfate/ ranging from 25-600 ug/day by stomach tube for 60 days. Total dose of 17 mg was administered. Mice were killed at 18 wk of age and 96% had lung tumors with average of 3 tumors/mouse. /no data on controls/

/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Administration of hydrazine to mice, rats and hamsters results in rapid methylation of liver DNA guanine for which endogenous formaldehyde appears to be the source of the methyl moiety. Hamsters were given hydrazine sulfate at 170, 340 and 510 mg/L in the drinking water for 2 years (average dose of 4.6, 8.3 and 10.3 mg hydrazine (free base)/kg bw over the 2-yr period), during which levels of methylation of DNA guanine in liver, kidney and lung, and histopathologic examinations of these tissues were carried out; dimethylnitrosamine, as a positive control, was administered at 10 mg/L in the drinking water (average dose of 1.1 mg/kg bw over the 4-month measurement period). Both 7-methylguanine and O6-methylguanine were readily detectable at 6 months exposure in hamsters given hydrazine or dimethylnitrosamine; in hydrazine-treated animals only trace amounts of these bases could be detected after 12 months exposure; these bases were again detected in liver DNA at exposure times of 18 and 24 months. Hepatocellular carcinomas were observed in hamsters treated at the highest dose of hydrazine sulfate after 78 weeks of exposure; the incidence of liver cancer was dose-related over the course of the experiment: 32% for hamsters exposed to 510 mg hydrazine sulfate/L, 12% for 340 mg/L and none at 170 mg/L. Hamsters given dimethylnitrosamine developed high levels of 7-methylguanine and even higher levels of O6-methylguanine and both liver cholangiocellular carcinomas (73% incidence), as reported before, and hepatocellular carcinomas (27% incidence), a new finding. These results demonstrate that hydrazine is a liver carcinogen in the hamster and provide information regarding the accumulation of DNA damage during the entire induction period for the carcinomas.

/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ In groups of 19-26 male and female BALB/c/Cb/Se mice the incidence of pulmonary tumors produced by /hydrazine sulfate from oral administration/ was shown to be dose dependent. Lowest dose used (21 mg) produced incidence of 54% in males and 32% in females surviving up to 78 wk. In control mice 24% of males and 4% of females developed pulmonary tumors mostly between 90 and 100 wks.

For more Non-Human Toxicity Excerpts (Complete) data for HYDRAZINE SULFATE (12 total), please visit the HSDB record page.

Populations at Special Risk · 1 Eintrag

Biological half-lives were significantly different among the three acetylation phenotypes (analysis of variance, P < 0.05): 3.94+/-1.70 hours for slow acetylators, 2.25+/-0.37 hours for intermediate acetylators, and 1.86+/-0.67 hours for rapid acetylators. /Hydrazine/

Evidence for Carcinogenicity · 2 Einträge

The IARC Working Group concluded that hydrazine (Group 2B) is possibly carcinogenic to humans. /Hydrazine sulfate was reviewed by the IARC Working Group. Data for it are published in the IARC Monograph V4 (1974). No evaluation of the carcinogenicity for hydrazine sulfate is given./

Hydrazine Sulfate: reasonably anticipated to be a human carcinogen.

Antidote and Emergency Treatment · 5 Einträge

Specific treatment for exposure consists of thorough washing of all exposed skin areas with soap and water, copious irrigation of the eyes, and prompt removal of the patient from the source of exposure. /Hydrazines/

After inhalation, observation for progressive respiratory distress is necessary. Chest X-ray and arterial blood gases should be monitored. Administration of oxygen, intubation, and assisted ventilation may become necessary. Pneumonia and bronchitis need to be excluded. /Hydrazines/

Pyridoxine may be antidotal. ...Seizures should be controlled with diazepam, phenytoin, or phenobarbital. Blood sugar levels should be monitored for severe hypoglycemia, which may appear with or without preceding significant hyperglycemia. The patient should be observed for evidence of intravascular hemolysis, methemoglobinemia, and consequent deterioration of renal function. Patients who are symptomatic or who demonstrate a methemoglobin level greater than 30 per cent should be treated with methylene blue slowly IV every 4 hours as needed. Improvement is dramatic if diagnosis is correct. Liver function should be monitored because hydrazines are known hepatotoxins. /Hydrazines/

Elimination is enhanced by forced diuresis and acidification of the urine. Hemodialysis and peritoneal dialysis should be effective, but insufficient human data exist on the use of these modalities. Treatment is otherwise symptomatic and supportive. /Hydrazines/

For more Antidote and Emergency Treatment (Complete) data for HYDRAZINE SULFATE (6 total), please visit the HSDB record page.

RAIS Toxicity Values · 4 Einträge

0.0049

IRIS Current

3

IRIS Current

Non-Human Toxicity Values · 4 Einträge

LD50 Mouse ip 152 mg/kg

LD50 Mouse oral 740 mg/kg

LD50 Rat ip 230 mg/kg

LD50 Rat oral 601 mg/kg

Hazard Quotient Level 0.1 or Cancer Risk Level 1E-06 · 6 Einträge

2.30e-01

1.10e+00

5.70e-04

2.50e-03

2.60e-02

5.00e+01

Sicherheitsdaten

wgk
3
tsca
TSCA listed
ridadr
UN 2923 8/PG 3
hs_code
28251090
RTECS-Nr.
MV9625000
risk_code
45-23/24/25-43-50/53-35
Toxizität
Hydrazine sulfate is moderately toxic. Symptoms of ingestion are paresthesia, somnolence, nausea, and vomiting. It also is an irritant to the eye. It is a confirmed carcinogen and an experimental teratogen.
hazard_code
T,N
safety_code
53-45-60-61-36/37/39-26
hazard_class
8
packing_group
II
Speicherklasse
6.1D - Non-combustible acute toxic Cat.3toxic hazardous materials or hazardous materials causing chronic effects
Giftige Stoffe Daten
10034-93-2(Hazardous Substances Data)
Hazard Classifications
Acute Tox. 3 DermalAcute Tox. 3 InhalationAcute Tox. 3 OralAquatic Acute 1Aquatic Chronic 1Carc. 1BEye Dam. 1Skin Corr. 1Skin Sens. 1

Verwendung und Herstellung

Uses · 6 Einträge

Used in the gravimetric estimation of nickel, cobalt, and cadmium; in the refining of rare metals; in separating polonium from tellurium; for determination of arsenic in metals; in condensation reactions; and to make hydrazine hydrate and other chemicals; Also used as an antioxidant in soldering flux for light metals, a reducing agent in the analysis of minerals and slags, a catalyst in making acetate fibers, and a germicide to destroy fungi and molds; [HSDB]

Soldering [Category: Heat or Machine]

In the gravimetric estimation of nickel, cobalt and cadmium; in the refining of rare metals; antioxidant in soldering flux for light metals; as reducing agent in the analysis of minerals and slags; in separating polonium from tellurium; in tests for blood; for destroying fungi and molds; in the preparation of hydrazine hydrate.

Manufacture of chemicals, condensation reactions, catalyst in making acetate fibers. Analysis of minerals, slags, and fluxes; determination of arsenic in metals; separation of polonium from tellurium; fungicide, germicide.

MEDICATION

MEDICATION (VET)

Methods of Manufacturing · 2 Einträge

Industrial preparation by the action of sodium hypochlorite on urea in the presence of sodium hydroxide.

Prepared by Raschig synthesis: 2NH3(aq) + (Ca(OCl)2/Na2CO3/colloid) and treatment with sulfuric acid. Starch, glue, or gelatin are used as colloids, and sodium hypochlorite may be used instead of bleaching powder.

General Manufacturing InformationHydrazine, sulfate (1:1): ACTIVE
Anwendungen · 2 Einträge

BeschreibungHydraziniumsulfat bildet farblose, dicke Tafeln oder Prismen mit einem Schmelzpunkt von 254 ℃. Die Kristalle sind in kalten Wasser schwer löslich (3.05 g in 100 ml bei 22 ℃), in heißem Wasser unter Hydrolyse zu N2H5+ und H3O+ leicht löslich und in Ethanol unlöslich. Hydraziniumsulfat wird als Reduktionsmittel bei der Mineralanalyse, zur Trennung von Polonium und Tellur, in der Photographie zur Beschleunigung des Entwickelns, als Fungizid und zur Herstellung von Aziden verwendet.

VerwendenHydrazine sulfate is used in the gravimetric estimation of nickel, cobalt and cadmium; in the refining of rare metals; as an antioxidant in soldering flux for light metals; as a reducing agent in the analysis of minerals and slags; in separating polonium from tellurium; in tests for blood; for destroying fungi and molds; in the preparation of hydrazine hydrate; press ure stabilizer in cutting oils.

Darstellung · 1 Eintrag

synthetischeHydrazine sulfate may be synthesized from aqueous ammonia and sodium hypochlorite solution in a two-step process. In the first stage, aqueous solution of ammonia is boiled with a normal solution of sodium hypochlorite in the presence of 10% gelatin solution to yield hydrazine. In the second stage, the hydrazine solution is ice-cooled followed by slow addition of concentrated sulfuric acid (Adams, R., and B.K. Brown. 1964. In Organic Synthesis, Collective Volume I, ed. H. Gilman and A. H. Blatt, 2nd ed. pp 309-310, New York: John Wiley & Sons). The reaction steps are as follows: 2NH3 + NaOCl → NH2NH2 + H2O + NaCl NH2NH2 + H2SO4 → NH2NH2 •H2SO4

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

NatriumhypochloritHarnstoffKaliumpermanganatNatriumhydroxidSchwefelsure

Nachgelagerte Produkte

Thiosemicarbacid3-Phenyl-1H-pyrazole-5-carboxamide ,97%Ethyl 3-(3-chlorophenyl)-1H-pyrazole-5-carboxylate ,97%5-(3-Chlorophenyl)-1H-pyrazole-3-carboxylic acid3-(4-Methoxyphenyl)-1H-pyrazole-5-carboxamide ,97%1(2H)-Phthalazinon3-(4-Chlorophenyl)-1H-pyrazole-5-carbohydrazide5-Amino-1,3,4-thiadiazole-2-thiol3-(4-Methoxyphenyl)-1H-pyrazole-5-carbohydrazide3-(3-Chlorophenyl)-1H-pyrazole-5-carbohydrazide ,97%1-ChlorophthalazineAminoguanidiniumhydrogencarbonat5-(4-Methoxy-phenyl)-2H-pyrazole-3-carboxylic acid ethyl ester5-(4-Chlorophenyl)-1H-pyrazole-3-carboxylic acid2,4-Dinitrophenylhydrazin2-(Acetamido)-5-(chlorosulfonyl)-1,3,4-thiadiazole3-(3-Chlorophenyl)-1H-pyrazole-5-carboxamide ,97%3-(4-Chlorophenyl)-1H-pyrazole-5-carboxamide ,97%Hydrazodicarbothioamid3-Phenyl-1H-pyrazole-5-carbohydrazideToluol-4-sulfonohydrazidPyridazin-3,6-diolAzelastineSemicarbazidEthyl 3-(4-chlorophenyl)-1H-pyrazole-5-carboxylateAminoguanidinium CarbonateN'-Benzoylbenzohydrazid5-Phenyl-1H-pyrazole-3-carboxylic acid5-Phenyl-2H-pyrazole-3-carboxylic acid ethyl ester1,2-Dimethylhydrazin-dihydrochlorid5-(4-Methoxyphenyl)-1H-pyrazole-3-carboxylic acidBismerthiazolAminoguanidiniumsulfat